Pharmaceutical Innovation & Production Opportunities in the Edmonton Region

Join us for an interactive roundtable discussion moderated by Stefan Scherer, Senior Business Development Manager for Edmonton Global, with:

• Greg Klak, VP of Operations and General Manager for GILEAD. Gilead is a global biopharmaceutical firm that established a manufacturing facility in the Edmonton Region to expand their success in North America.
• Andrew MacIsaac, CEO, Applied Pharmaceutical Innovation. API is a non-for-profit that works closely with industry, academia and health institutes, offering a first-in-class model for the commercialization of pharmaceutical research.
• Michael Overduin, Professor & Researcher, University of Alberta, Co-founder & Co-director, DiscoveryLab
• and Canada’s Senior Trade Commissioners in the Netherlands (Sameena Qureshi) and Belgium/Luxembourg (Michelle Gartland)

During this webinar, you will learn about Edmonton Region’s strengths in the pharmaceutical ecosystem including:

• Advanced research at the University of Alberta;
• Advantages of Edmonton International Airport as Canada’s only cold chain pharma certified airport, uniquely positioned to take a leading role in the global pharmaceutical supply chain;
• Preferred market access to 51 countries including the European Union with the Comprehensive Economic and Trade Agreement (CETA).

Additionally, Edmonton Region has a talented workforce and competitive business environment, making it ideal for companies considering expansion or looking for innovation partners in North America and internationally.

We welcome you to register for the seminar here: https://edmontonglobal.ca/pharmaceutical-innovation-and-production-opportunities-in-the-edmonton-metropolitan-region/.

In the meantime, please take a look at Edmonton Region’s Life Sciences page to learn more about this industry leading area of Canada: https://edmontonglobal.ca/life-sciences/ and https://edmontonglobal.ca/downloads/